Literature DB >> 10657582

Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples?

A R Miserez1, P Y Muller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10657582     DOI： 10.1016/s0021-9150(99)00470-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  8 in total

1.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

Review 2.  ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature.

Authors:  Amira S Sabbagh; Rose T Daher; Zaher K Otrock; Rabab N Abdel Khalek; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2006-12-08       Impact factor: 2.316

Review 3.  Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.

Authors:  Jooho Lee; Robert A Hegele
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

4.  Decreased bone mineral density in subjects carrying familial defective apolipoprotein B-100.

Authors:  Laura M Yerges-Armstrong; Haiqing Shen; Kathleen A Ryan; Elizabeth A Streeten; Alan R Shuldiner; Braxton D Mitchell
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

5.  Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB.

Authors:  Bernard Khoo; Xavier Roca; Shern L Chew; Adrian R Krainer
Journal:  BMC Mol Biol       Date:  2007-01-17       Impact factor: 2.946

6.  Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia.

Authors:  Faina M Zakharova; Dorte Damgaard; Michail Y Mandelshtam; Valery I Golubkov; Peter H Nissen; Gitte G Nilsen; Anette Stenderup; Boris M Lipovetsky; Vladimir O Konstantinov; Alexander D Denisenko; Vadim B Vasilyev; Ole Faergeman
Journal:  BMC Med Genet       Date:  2005-02-08       Impact factor: 2.103

Review 7.  Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.

Authors:  Ivan Pećin; Merel L Hartgers; G Kees Hovingh; Ricardo Dent; Željko Reiner
Journal:  Eur J Prev Cardiol       Date:  2017-06-23       Impact factor: 7.804

8.  Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters.

Authors:  Veronika Todorovova; Tereza Altschmiedova; Michal Vrablik; Richard Ceska
Journal:  Front Genet       Date:  2022-02-28       Impact factor: 4.599
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.